This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights: Lam Research, Xylem, Omega Healthcare Investors, Celanese and Electronic Arts
by Zacks Equity Research
Zacks.com featured highlights: Lam Research, Xylem, Omega Healthcare Investors, Celanese and Electronic Arts
5 Best Stocks with Impressive Sales Growth to Buy Right Now
by Zacks Equity Research
Sales growth is an important indicator of a company's health and ability to sustain its business.
Celanese (CE) to Expand Capacity at Selected Facilities
by Zacks Equity Research
Celanese (CE) plans to drive growth in its engineered materials business by adding new production lines and expanding selective facilities.
Celanese (CE) Beats Earnings and Revenue Estimates in Q3
by Zacks Equity Research
Commercial execution in the Acetyl Chain unit and productivity gains contributed to Celanese's (CE) Q3 results.
Celanese (CE) Declares Completion of Debottleneck Projects
by Zacks Equity Research
Celanese (CE) completes major debottlenecking projects and product transfers at its global engineered materials facilities to support project pipeline growth and meet customer demand.
Celanese (CE) Announces Price Hike of Selective Products
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Celanese (CE) Set to Increase Prices of Emulsion Polymers
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Celanese (CE) to Increase Prices of Acetyl Intermediates
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Celanese (CE) Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Celanese's (CE) shares scale a fresh 52-Week high on upbeat growth prospects in 2017.
Celanese (CE) Announces Rise in Price of Selective Products
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Celanese (CE) Shares Up 27% YTD: What's Driving the Stock?
by Zacks Equity Research
Forecast-topping earnings performance and upbeat outlook have contributed to a rally in Celanese's (CE) shares.
Celanese (CE) Announces Price Hike of Selective Products
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Celanese (CE) to Raise Prices of Selective Acetyl Products
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Celanese to Hike Price for Acetyl Intermediates Products
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Why Is Celanese (CE) Down 1.7% Since the Last Earnings Report?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Celanese (CE) to Increase Price of Vinyl Acetate Monomer
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Celanese (CE) Poised on Productivity Actions, Acquisitions
by Zacks Equity Research
Celanese Corporation's (CE) cost saving and productivity actions as well as acquisitions are expected to lend support to earnings in 2017. However, the company is exposed to pricing pressure.
Celanese (CE) to Raise Prices of Acetyl Intermediate Products
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
International Flavors (IFF) Q2 Earnings: A Beat in Store?
by Zacks Equity Research
International Flavors & Fragrances Inc. (IFF) second-quarter results will likely benefit from business expansion in emerging markets, solid product portfolio and focus on research and development.
Celanese (CE) Beats Earnings and Revenue Estimates in Q2
by Zacks Equity Research
Both Acetyl Chain and Materials Solutions units contributed to the strong performance of Celanese (CE) in the second quarter.
Celanese (CE) Scales New 52-Week High on Bright Prospects
by Zacks Equity Research
Celanese's (CE) shares are scaling new highs on solid prospects driven by the joint venture deal with Blackstone and the buyout of Nilit's business.
Celanese (CE) Board Clears New $1.5B Share Repurchase Program
by Zacks Equity Research
Celanese's board of directors approves $1.5 billion share repurchase program that represents approximately 11% of the company's outstanding shares.
Celanese (CE) to Hike Prices of Acetyl Intermediate Products
by Zacks Equity Research
Celanese (CE) announced that it will increase the list and off-list selling prices for certain acetyl intermediate products including Vinyl Acetate Monomer and Acetic Anhydride.
Celanese (CE) to Raise Prices of Ethyl Acetate in Europe
by Zacks Equity Research
Celanese (CE) announced that it will increase the list and off-list selling prices for ethyl acetate in Europe by ???150 per MT.
Celanese (CE) Declares Price Hike for Selective Products
by Zacks Equity Research
Celanese Corporation (CE) said that it will increase the selling prices of selective products like Dibutyl Maleate (DBM), Dioctyl Maleate (DOM) and Plasticizer WVC 3800.